Aetna ERISA Subrogation: Self-Funded Plan Challenges and Pharmacy Lien Priority in PI Settlements
James Wong — Founder & Pharmacist, LienScripts | March 26, 2025 | 8 min read
Aetna administers thousands of self-funded ERISA plans whose subrogation provisions are governed by federal law — not state insurance protections. When ERISA preempts state-law made-whole and anti-subrogation statutes, PI attorneys face a harder negotiation. Pharmacy liens from LienScripts remain entirely outside Aetna's subrogation reach because Aetna never paid for lien-dispensed medications.
A pharmacy lien is a legal claim against personal injury settlement proceeds for prescription medications provided on credit. Aetna ERISA subrogation in self-funded plans presents one of the most challenging reimbursement scenarios for PI attorneys because ERISA preempts the state-law protections that reduce fully insured plan subrogation demands. Pharmacy liens from LienScripts operate entirely outside this framework — Aetna has no subrogation interest in medications it never paid for.
- Aetna administers self-funded ERISA plans for thousands of large employers, with subrogation governed by the plan document and federal law — not state insurance protections
- ERISA preemption eliminates state-law made-whole doctrines and anti-subrogation statutes for self-funded plans, giving Aetna stronger recovery rights
- Pharmacy liens from LienScripts are entirely outside Aetna's subrogation interest because lien-dispensed medications are never billed to or paid by Aetna
- The common fund doctrine remains available under US Airways v. McCutchen when the plan document is silent on allocation of attorney fees
- Plan document analysis is the threshold step — every Aetna ERISA subrogation defense begins with the specific plan language
This post is for informational purposes only and does not constitute legal advice.
Why Aetna ERISA Subrogation Is Different
Aetna operates in two distinct capacities in the health insurance market:
Fully insured plans. Aetna bears the insurance risk. State insurance law governs, including state-law made-whole doctrines and anti-subrogation statutes. These are the more plaintiff-protective cases.
Self-funded ERISA plans. The employer bears the financial risk; Aetna serves as the third-party administrator (TPA). ERISA preempts state insurance laws. The plan document — not state law — controls subrogation rights and remedies.
The distinction matters enormously. In a fully insured Aetna plan, the made-whole doctrine may reduce or eliminate the subrogation demand. In a self-funded ERISA plan, the made-whole doctrine as a state-law matter is preempted, and Aetna's recovery rights are determined by the plan document and federal common law.
[!KEY] The threshold question in every Aetna subrogation matter: Is this a fully insured Aetna plan or a self-funded ERISA plan administered by Aetna? The answer determines the entire legal framework. Request the Summary Plan Description from the client or plan administrator immediately.
ERISA Preemption and the Plan Document
Under ERISA section 514(a), ERISA preempts state laws that "relate to" employee benefit plans. For self-funded plans, this means:
- State-law made-whole doctrines: Preempted. The plan does not need to wait until the plaintiff is fully compensated before recovering.
- State anti-subrogation statutes: Preempted. State laws that prohibit or limit health insurer subrogation do not apply to self-funded ERISA plans.
- State common fund rules: Preempted as applied to self-funded plans, though a federal equitable common fund doctrine may apply.
The plan document becomes the controlling instrument. Aetna's self-funded plan documents typically contain detailed reimbursement and subrogation provisions that:
- Assert a first-priority right to recovery from any third-party settlement
- Reject the made-whole doctrine explicitly
- Reject the common fund doctrine explicitly
- Require the plan member to reimburse the plan from any recovery, regardless of whether the member is fully compensated
- Grant the plan a constructive trust or equitable lien over settlement proceeds
According to James Wong, PharmD, founder of LienScripts, "Aetna's ERISA subrogation provisions are drafted to maximize recovery. The plan document often explicitly rejects every defense available under state law. That makes the distinction between plan-paid medical costs and pharmacy lien costs even more important — pharmacy lien medications were never paid by the plan and fall entirely outside this framework."
[!TIP] Obtain the full plan document — not just the Summary Plan Description — for self-funded plans. The SPD is a summary; the actual plan document may contain more detailed subrogation provisions. File a written request under ERISA section 104(b)(4).
Available Defenses for ERISA Self-Funded Plans
While ERISA preemption narrows the defense landscape, several strategies remain:
1. Common Fund Doctrine Under McCutchen
The Supreme Court in US Airways, Inc. v. McCutchen, 569 U.S. 88 (2013), held that equitable principles — including the common fund doctrine — apply as gap-fillers where the plan document is silent. If the Aetna self-funded plan document does not expressly address allocation of attorney fees and costs, the common fund doctrine requires the plan to share proportionately in the fees that created the recovery.
Practical application: Review the plan document for express language on attorney fee allocation. If silent, the common fund reduction is available. If the plan expressly rejects common fund, McCutchen does not override that language.
2. Causation Challenges on Individual Line Items
Aetna's benefits-paid list is generated from claims data and may include items that predate the accident, relate to unconnected conditions, or are only peripherally associated with the injury. Line-by-line review against the medical records can reduce the base amount before applying other reductions.
3. Montanile and the Dissipated Funds Defense
In Montanile v. Board of Trustees, 577 U.S. 136 (2016), the Supreme Court held that ERISA's equitable lien attaches only to specifically identifiable funds. If settlement proceeds have been dissipated before the plan seeks recovery, the equitable lien may not be enforceable. This is a narrow defense with significant ethical considerations — consult applicable rules of professional responsibility.
4. Knudson and the Equitable Remedy Limitation
Under Great-West Life & Annuity Insurance Co. v. Knudson, 534 U.S. 204 (2002), ERISA plan subrogation is limited to equitable remedies. If the plan seeks a legal remedy rather than an equitable one, the recovery may be barred. This analysis turns on how the settlement funds are held and whether the plan can trace them to an identifiable fund.
[!KEY] Even in the most plan-favorable ERISA subrogation scenario, pharmacy lien costs from LienScripts are outside the plan's recovery reach. Aetna's equitable lien attaches to benefits the plan paid — not to medications provided by a lien pharmacy that never billed the plan.
Pharmacy Liens: Outside the ERISA Subrogation Framework
LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. Regardless of whether the Aetna plan is fully insured or ERISA self-funded, pharmacy liens from LienScripts are entirely outside the subrogation framework:
- The lien pharmacy extends credit directly to the patient. No insurance claim is filed.
- Aetna never pays for lien-dispensed medications. There is no Aetna payment to recover.
- The pharmacy lien is resolved through a separate process between the attorney and LienScripts.
- ERISA preemption is irrelevant to pharmacy lien costs because the plan has no interest to preempt.
This structural independence means that even in the most challenging ERISA self-funded plan scenario — where the plan document rejects made-whole, rejects common fund, and asserts first-priority recovery — pharmacy lien costs remain unaffected. The plan cannot recover what it never paid.
As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Enrolling clients in the LienScripts pharmacy lien program at intake ensures that all injury medications are provided outside the insurance benefit — outside Aetna's claims data, outside the benefits-paid list, and outside the subrogation demand. This is not a workaround; it is the structural reality of how pharmacy liens operate."
Settlement Waterfall with Aetna ERISA Subrogation
- Gross settlement received.
- Attorney fees and costs deducted.
- Aetna ERISA subrogation negotiated: common fund (if available), causation challenges, plan document analysis.
- Pharmacy lien resolved separately with LienScripts; written release obtained.
- Net proceeds distributed to client.
[!TIP] In ERISA self-funded cases where the plan document is highly unfavorable, focus reduction efforts on causation challenges and common fund where available. The pharmacy lien — resolved independently — provides a stable, predictable cost that is unaffected by the ERISA negotiation outcome.
Practical Steps for Attorneys
- Identify whether the plan is self-funded or fully insured. Request the SPD and plan document.
- Analyze the plan document's subrogation provisions. Identify whether made-whole, common fund, and fee allocation are addressed.
- Enroll the client in LienScripts at intake. Keep injury medications outside Aetna's claims system.
- Challenge the benefits-paid list line by line. Remove items unrelated to the accident.
- Apply available defenses. Common fund under McCutchen where the plan is silent; causation challenges on individual items.
- Resolve the pharmacy lien separately. The pharmacy lien negotiation proceeds independently of the ERISA subrogation.
- Obtain written releases from both before distributing proceeds.
Key Takeaway
Aetna ERISA self-funded plan subrogation is among the most challenging reimbursement scenarios in PI practice because ERISA preempts state-law protections. The plan document controls, and Aetna's plans are drafted to maximize recovery. Pharmacy liens from LienScripts are structurally outside this framework — Aetna never pays for lien-dispensed medications, so there is nothing for the plan to recover. Enrolling clients at intake and resolving the pharmacy lien independently protects settlement value regardless of the ERISA outcome.
Related Resources
- Aetna Subrogation and Pharmacy Liens in PI Settlements
- Health Insurance Subrogation vs. Pharmacy Liens
- Cigna Subrogation and Pharmacy Lien Defense
- UHC Subrogation and Pharmacy Liens
Frequently Asked Questions
Why is Aetna ERISA subrogation harder to negotiate than fully insured plan subrogation?
ERISA preempts state-law protections that benefit plaintiffs in fully insured plan subrogation — including state made-whole doctrines and anti-subrogation statutes. For self-funded plans administered by Aetna, the plan document controls, and Aetna's plan documents typically reject made-whole and common fund defenses explicitly. Available defenses are limited to federal equitable principles and plan document analysis.
Can Aetna's ERISA subrogation reach pharmacy lien costs?
No. Aetna's subrogation interest — whether under a fully insured or ERISA self-funded plan — covers only benefits the plan actually paid. Medications dispensed through a pharmacy lien are never billed to Aetna and never paid by the plan. There is no payment for Aetna to recover, regardless of how strong the plan's subrogation provisions are.
Does the common fund doctrine apply to Aetna ERISA self-funded plans?
Under US Airways v. McCutchen (2013), the common fund doctrine applies as an equitable gap-filler when the plan document is silent on attorney fee allocation. If the plan document expressly addresses and rejects the common fund doctrine, McCutchen does not override that language. Review the full plan document — not just the SPD — for express provisions on fee allocation.